These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30657957)

  • 41. Splicing, genome stability and disease: splice like your genome depends on it!
    Tam AS; Stirling PC
    Curr Genet; 2019 Aug; 65(4):905-912. PubMed ID: 30953124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma.
    Kumar D; Das M; Oberg A; Sahoo D; Wu P; Sauceda C; Jih L; Ellies LG; Langiewicz MT; Sen S; Webster NJG
    Adv Sci (Weinh); 2022 Jul; 9(21):e2105120. PubMed ID: 35615981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of cellular RNA nano-particle assembly by splicing factor SRp20.
    Yoon SP; Kim HH; Kim J; Park RY; Ohn T
    J Nanosci Nanotechnol; 2013 Jan; 13(1):184-7. PubMed ID: 23646715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology.
    Gonçalves V; Jordan P
    Biomed Res Int; 2015; 2015():287048. PubMed ID: 26273603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alternative splicing and cancer: a systematic review.
    Zhang Y; Qian J; Gu C; Yang Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):78. PubMed ID: 33623018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer.
    Hall AE; Pohl SÖ; Cammareri P; Aitken S; Younger NT; Raponi M; Billard CV; Carrancio AB; Bastem A; Freile P; Haward F; Adams IR; Caceres JF; Preyzner P; von Kriegsheim A; Dunlop MG; Din FV; Myant KB
    Nat Commun; 2022 May; 13(1):2791. PubMed ID: 35589755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of transcription of the RNA splicing factor hSlu7 by Elk-1 and Sp1 affects alternative splicing.
    Alberstein M; Amit M; Vaknin K; O'Donnell A; Farhy C; Lerenthal Y; Shomron N; Shaham O; Sharrocks AD; Ashery-Padan R; Ast G
    RNA; 2007 Nov; 13(11):1988-99. PubMed ID: 17804646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
    Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
    Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis.
    Song S; Zhang W; Li Q; Wang Z; Su Q; Zhang X; Li B; Zhuang W
    Br J Cancer; 2023 Apr; 128(6):1086-1094. PubMed ID: 36593359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The High Level of Aberrant Splicing of ISCU in Slow-Twitch Muscle May Involve the Splicing Factor SRSF3.
    Rawcliffe DF; Österman L; Lindsten H; Holmberg M
    PLoS One; 2016; 11(10):e0165453. PubMed ID: 27783661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.
    Zhu S; Chen Z; Katsha A; Hong J; Belkhiri A; El-Rifai W
    Oncogene; 2016 Apr; 35(14):1847-56. PubMed ID: 26119931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction and evaluation of an adenoviral vector for the liver-specific expression of the serine/arginine-rich splicing factor, SRSF3.
    Suchanek AL; Salati LM
    Plasmid; 2015 Nov; 82():1-9. PubMed ID: 26241824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RBM4a-SRSF3-MAP4K4 Splicing Cascade Constitutes a Molecular Mechanism for Regulating Brown Adipogenesis.
    Peng HY; Liang YC; Tan TH; Chuang HC; Lin YJ; Lin JC
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryptococcus neoformans Slu7 ensures nuclear positioning during mitotic progression through RNA splicing.
    Krishnan VP; Negi MS; Peesapati R; Vijayraghavan U
    PLoS Genet; 2024 May; 20(5):e1011272. PubMed ID: 38768219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.
    Guo J; Jia J; Jia R
    Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cell-based splicing reporter system to identify regulators of cis-splicing between adjacent genes.
    Chwalenia K; Qin F; Singh S; Li H
    Nucleic Acids Res; 2019 Feb; 47(4):e24. PubMed ID: 30590765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic targeting of splicing in cancer.
    Lee SC; Abdel-Wahab O
    Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SRSF3 promotes pluripotency through
    Ratnadiwakara M; Archer SK; Dent CI; Ruiz De Los Mozos I; Beilharz TH; Knaupp AS; Nefzger CM; Polo JM; Anko ML
    Elife; 2018 May; 7():. PubMed ID: 29741478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How Slu7 and Prp18 cooperate in the second step of yeast pre-mRNA splicing.
    James SA; Turner W; Schwer B
    RNA; 2002 Aug; 8(8):1068-77. PubMed ID: 12212850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors.
    Bielli P; Pagliarini V; Pieraccioli M; Caggiano C; Sette C
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.